Solvemed Group is a Neuroscience AI company working to redefine patient care and drug discovery. With the primary focus in Parkinson’s disease, Solvemed leverages its proprietary machine learning technology to develop novel diagnostic-predictive digital biomarkers to enable first-in-class, accurate, early and cost-effective diagnostic and monitoring tools.
Member count: 11-50
Investors 2
| Date | Name | Website |
| 09.02.2021 | Rheingau F... | rheingau-f... |
| 10.06.2021 | PFR Ventur... | pfrventure... |